Skip to main content
Equibles
RCEL logo

RCEL · AVITA Medical, Inc.

Track RCEL — free Ask ALVIS about RCEL
$4.52 +0.08 (+1.80%)
Going-concern doubt — flagged May 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on the Company's liquidity position and the Company's current forecast of operating results and cash flows, management determined there is substantial doubt about the Company's ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to the Company's debt repayment obligations, recurring losses, and historical negative cash flows.”
View the 10-Q filed May 14, 2026
Market Cap
$136.65M
Shares
30.78M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.44 Open$4.61 Day$4.37–4.68 52W$3.22–7.12 Avg vol 30d342K Short int2.6M · 8.5% float · 7.8d Short vol50% Last earningsMay 14, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 14

Up next

Next earnings call
Aug 13, 2026 Est · unconfirmed · in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 14, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 20.7 · elevated Equity put/call 0.61
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +6%
      above
      Price vs 50-day avg +2%
      above
      RSI (14) 47
      neutral
      MACD trend Negative
      52-week position 31%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +8%
      trailing
      6-month return +9%
      trailing
      YTD return +29%
      this year
      Relative strength +3%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $4 › 200d $4 — 50d above 200d
      Institutional flow Distributing
      19 of 79 funds reported for Jun 30 · net -15.1K sh shares · +2 new
      Insider flow Accumulating
      Net +$205.6K over 90 days · 0% sells
      Short interest Rising
      8.50% of float · ▲ +3.4% MoM · 7.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      79 holders — mid 3-yr range
      Squeeze score 80
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +11%
      Y/Y
      Gross margin 82%
      contracting
      EPS growth +27%
      Y/Y
      Free cash flow $-32.2M
      Balance sheet $32.7M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 91%
      annualized · 1-yr
      Max drawdown −52%
      past year
      ATR 8.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 14, 2026
      Total revenue · Full year 2026 Initiated $80M – $85M
      prior FY $71.61M midpoint +15.2% Y/Y

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +6% Bullish
      Price vs 50-day avg
      +2% Bullish
      RSI (14)
      47 Neutral
      MACD trend
      Negative Bearish
      52-week position
      31% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $4 › 200d $4 — 50d above 200d
      Institutional flow Distributing
      19 of 79 funds reported for Jun 30 · net -15.1K sh shares · +2 new
      Insider flow Accumulating
      Net +$205.6K over 90 days · 0% sells
      Short interest Rising
      8.50% of float · ▲ +3.4% MoM · 7.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      79 holders — mid 3-yr range
      Price context
      position in its 52-week range
      52-wk low $3 Now $4 · 31% 52-wk high $7
      vs 200-day avg +6% vs 50-day avg +2%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RCEL
      AVITA Medical, Inc.
      this stock
      		$136.65M +28.7% +11.5% — 8.5%
      ABT
      Abbott Laboratories
      		 $188.12B -13.4% +5.7% 30.3 1.4%
      SYK
      Stryker Corp
      		 $135.04B +0.5% +11.2% 40.8 1.8%
      MDT
      Medtronic plc
      		 $112.06B -8.1% +8.4% 23.5 1.5%
      BSX
      Boston Scientific Corp
      		 $67.29B -51.7% +5.5% 19.3 1.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      74
      % held
      283.2%
      Reported
      19 of 79
      Top holder
      ORBIMED ADVISORS LLC
      Held Float
      View
      Held by Funds
      Fund positions
      81
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      2.6M
      Days to cover
      7.8d
      Change
      +87.2K sh
      View
      Short Volume
      Short vol %
      50%
      As of
      Jul 29, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      8.6K
      Value
      $34.1K
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      44.8%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$205.6K
      Buyers / Sellers
      2 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $71.6M
      Net income (FY)
      $-48.6M
      EPS diluted
      $-1.74
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 8, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $2.1M
      Shares
      122.5K
      Filed
      Jun 8, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 14, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      RCEL -10.1% +7.5% +8.8% +7.5% +28.7%
      SPY -2.4% -2.3% +6.3% -2.3% +7.0%
      vs SPY -7.7% +9.8% +2.5% +9.8% +21.7%
      Key facts CIK 1762303 CUSIP 05380C102 13F (30d) 12 filings 12 filers Visit website

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)